Free Trial

Legend Biotech (LEGN) Competitors

Legend Biotech logo
$43.36 -0.85 (-1.92%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$43.23 -0.13 (-0.31%)
As of 07/25/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LEGN vs. BNTX, SMMT, INSM, TEVA, GMAB, RDY, MRNA, QGEN, VTRS, and ASND

Should you be buying Legend Biotech stock or one of its competitors? The main competitors of Legend Biotech include BioNTech (BNTX), Summit Therapeutics (SMMT), Insmed (INSM), Teva Pharmaceutical Industries (TEVA), Genmab A/S (GMAB), Dr. Reddy's Laboratories (RDY), Moderna (MRNA), Qiagen (QGEN), Viatris (VTRS), and Ascendis Pharma A/S (ASND). These companies are all part of the "pharmaceutical products" industry.

Legend Biotech vs. Its Competitors

Legend Biotech (NASDAQ:LEGN) and BioNTech (NASDAQ:BNTX) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership and earnings.

BioNTech has a net margin of -27.37% compared to Legend Biotech's net margin of -29.95%. BioNTech's return on equity of -3.94% beat Legend Biotech's return on equity.

Company Net Margins Return on Equity Return on Assets
Legend Biotech-29.95% -21.19% -13.47%
BioNTech -27.37%-3.94%-3.41%

Legend Biotech presently has a consensus target price of $73.33, suggesting a potential upside of 69.13%. BioNTech has a consensus target price of $136.58, suggesting a potential upside of 18.45%. Given Legend Biotech's stronger consensus rating and higher probable upside, research analysts plainly believe Legend Biotech is more favorable than BioNTech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Legend Biotech
0 Sell rating(s)
1 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.91
BioNTech
0 Sell rating(s)
4 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
2.83

70.9% of Legend Biotech shares are held by institutional investors. Comparatively, 15.5% of BioNTech shares are held by institutional investors. 0.0% of Legend Biotech shares are held by company insiders. Comparatively, 19.2% of BioNTech shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Legend Biotech has a beta of 0.19, suggesting that its stock price is 81% less volatile than the S&P 500. Comparatively, BioNTech has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500.

In the previous week, Legend Biotech had 1 more articles in the media than BioNTech. MarketBeat recorded 9 mentions for Legend Biotech and 8 mentions for BioNTech. Legend Biotech's average media sentiment score of 1.34 beat BioNTech's score of 0.51 indicating that Legend Biotech is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Legend Biotech
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BioNTech
3 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Legend Biotech has higher earnings, but lower revenue than BioNTech. Legend Biotech is trading at a lower price-to-earnings ratio than BioNTech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Legend Biotech$627.24M12.70-$177.03M-$0.59-73.49
BioNTech$2.98B9.31-$719.92M-$3.40-33.91

Summary

Legend Biotech and BioNTech tied by winning 8 of the 16 factors compared between the two stocks.

Get Legend Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LEGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LEGN vs. The Competition

MetricLegend BiotechMED IndustryMedical SectorNASDAQ Exchange
Market Cap$7.97B$3.05B$5.70B$9.50B
Dividend YieldN/A2.37%4.58%4.00%
P/E RatioN/A21.3228.3920.07
Price / Sales12.70270.06427.4498.54
Price / CashN/A42.7636.2258.56
Price / Book7.618.378.675.88
Net Income-$177.03M-$55.19M$3.25B$258.89M
7 Day Performance4.26%5.86%4.30%3.70%
1 Month Performance29.51%17.29%10.57%11.71%
1 Year Performance-23.41%4.39%35.68%17.98%

Legend Biotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LEGN
Legend Biotech
3.6964 of 5 stars
$43.36
-1.9%
$73.33
+69.1%
-26.7%$7.97B$627.24M0.002,609Positive News
BNTX
BioNTech
1.4221 of 5 stars
$108.91
-1.0%
$136.58
+25.4%
+36.2%$26.18B$2.98B-32.036,772News Coverage
SMMT
Summit Therapeutics
2.5068 of 5 stars
$26.34
+0.5%
$34.67
+31.6%
+173.3%$19.56B$700K-77.47110Positive News
INSM
Insmed
3.9249 of 5 stars
$102.78
+0.2%
$108.47
+5.5%
+39.5%$19.50B$363.71M-17.271,271News Coverage
Analyst Forecast
Insider Trade
TEVA
Teva Pharmaceutical Industries
4.0118 of 5 stars
$16.30
+1.5%
$24.71
+51.7%
-1.6%$18.69B$16.54B-14.1736,830Positive News
Upcoming Earnings
Analyst Upgrade
Gap Up
GMAB
Genmab A/S
4.0851 of 5 stars
$21.69
-0.9%
$37.80
+74.3%
-16.8%$13.92B$3.12B12.322,682Positive News
RDY
Dr. Reddy's Laboratories
2.7387 of 5 stars
$14.57
+0.6%
$16.95
+16.4%
-9.3%$12.16B$3.81B22.0727,811Earnings Report
MRNA
Moderna
4.2974 of 5 stars
$30.97
-0.9%
$46.61
+50.5%
-71.6%$11.98B$3.24B-3.555,800Upcoming Earnings
Analyst Forecast
QGEN
Qiagen
3.6745 of 5 stars
$48.06
-0.6%
$49.40
+2.8%
+26.1%$10.68B$1.98B120.495,765Analyst Downgrade
Analyst Revision
VTRS
Viatris
2.432 of 5 stars
$8.90
+0.2%
$10.40
+16.9%
-20.0%$10.45B$14.74B-2.8132,000
ASND
Ascendis Pharma A/S
3.4338 of 5 stars
$168.02
-1.1%
$223.07
+32.8%
+24.6%$10.39B$368.70M-26.751,017Analyst Revision

Related Companies and Tools


This page (NASDAQ:LEGN) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners